Dollar General Corporation (NYSE:DG): Citigroup believes that when Dollar General is added to the S&P 500 after the market close on November 30, index funds are going to be necessary to purchase nearly 29.2 million shares, or 9.5 days of average daily volume. Citi claims that the demand should have the ability to drive a 6 percent increase in the stock price. The firm gives the stock a Buy rating and a $65 price target.
Gilead Sciences Inc. (NASDAQ:GILD) is believed by RBC Capital as being the best growth outlook among large cap companies, and the firm predicts that the company will report positive data on its HCV treatment during the next month. The firm keeps its Outperform rating on the stock.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Heartware International Inc. (NASDAQ:HTWR): A UBS consultant has noted the risk to HeartWare’s continuing ENDURANCE trial but is comfortable with HVAD, consistent with the firm’s view. The firm sees a rise in the stroke rate in HVAD IFU as raising risk above a trivial level. Shares have a Neutral rating.
Symantec Corporation (NASDAQ:SYMC) target was raised by RBC Capital since the firm predicts that the company will announce a reduction in its workforce on January 23. Also, the firm thinks the stock has the ability to advance after the January announcement, and it keeps its Outperform rating on the stock.
Phillips-Van Heusen Corp. (NYSE:PVH): Cowen recommends purchasing PVH Corp before tonight’s Q3 report. The firm said that updated guidance on October 31 suggests more confidence in its growth globally driven by Tommy and Calvin Klein brands market share gains. Shares have an Outperform rating.
Don’t Miss: Did James River Coal Deserve an Upgrade?